قارن الطرق

	مقياس جودة الحياة في القصور الكظري AddiQoL	AGHDA: تقييم قصور هرمون النمو لدى البالغين
المجال	علم الغدد الصماء	علم الغدد الصماء
العائلة	Process / pipeline	Process / pipeline
سنة النشأة	2012	2000
صاحب الطريقة	Adriana Evers, Jeanieke Tiemensma	Anthony Hunt, Garry Werther, Peter Wrightson
النوع	Patient self-report questionnaire	Patient self-report questionnaire
المصدر التأسيسي	Evers, A. C., & Tiemensma, J. (2012). AddiQoL: A disease-specific quality of life scale for patients with primary adrenal insufficiency. J Clin Endocrinol Metab, 97(10), 3501-3508.	Hunt, A. E., Werther, G. A., & Wrightson, P. (2000). The utility of AGHDA in identifying GH-deficient adults. Clin Endocrinol (Oxf), 52(3), 341-346.
الأسماء البديلة	Addison Quality of Life, AI-QoL	AGHDA-25
ذات صلة	3	3
الملخص	AddiQoL is a disease-specific quality of life questionnaire developed to assess the burden of primary and secondary adrenal insufficiency, encompassing physical, emotional, and social domains relevant to patients on glucocorticoid and mineralocorticoid replacement therapy. Developed by Evers and Tiemensma in 2012, it is the first formally validated instrument specifically designed for adrenal insufficiency populations.	The AGHDA is a 25-item disease-specific quality of life questionnaire designed to assess the burden of adult growth hormone (GH) deficiency. Developed by Hunt, Werther, and colleagues in 2000, it evaluates symptoms and functional impairments directly related to GH deficiency, including fatigue, reduced muscle strength, weight gain, and psychological difficulties. The instrument is widely used in endocrinology practice and clinical trials to quantify the impact of GH replacement therapy.